Drug Name and FDA Application Number | Dosage Form/Route | Strength | Marketing Status | Company |
NANDROLONE DECANOATE
(ANDA # 086385)
| INJECTABLE; INJECTION |
50MG/ML
|
Prescription
| WATSON LABS |
NANDROLONE DECANOATE
(ANDA # 086598)
| INJECTABLE; INJECTION |
100MG/ML
|
Prescription
| WATSON LABS |
NANDROLONE DECANOATE
(ANDA # 087519)
| INJECTABLE; INJECTION |
100MG/ML
|
Discontinued
| AKORN |
NANDROLONE DECANOATE
(ANDA # 087598)
| INJECTABLE; INJECTION |
50MG/ML
|
Discontinued
| WATSON LABS |
NANDROLONE DECANOATE
(ANDA # 087599)
| INJECTABLE; INJECTION |
100MG/ML
|
Discontinued
| WATSON LABS |
NANDROLONE DECANOATE
(ANDA # 088128)
| INJECTABLE; INJECTION |
200MG/ML
|
Prescription
| WATSON LABS |
NANDROLONE DECANOATE
(ANDA # 088290)
| INJECTABLE; INJECTION |
100MG/ML
|
Discontinued
| ABRAXIS PHARM |
NANDROLONE DECANOATE
(ANDA # 088317)
| INJECTABLE; INJECTION |
200MG/ML
|
Discontinued
| ABRAXIS PHARM |
NANDROLONE DECANOATE
(ANDA # 088554)
| INJECTABLE; INJECTION |
50MG/ML
|
Discontinued
| WATSON LABS |
NANDROLONE DECANOATE
(ANDA # 089248)
| Injectable; Injection |
50MG/ML
|
Discontinued
| QUAD PHARMS |
NANDROLONE DECANOATE
(ANDA # 089249)
| Injectable; Injection |
100MG/ML
|
Discontinued
| QUAD PHARMS |
NANDROLONE DECANOATE
(ANDA # 089250)
| Injectable; Injection |
200MG/ML
|
Discontinued
| QUAD PHARMS |